Group One Trading’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-200
Closed -$45.4K – 7667
2026
Q2
$45.4K Buy
+200
New +$35.6K ﹤0.01% 5463
2025
Q4
– Sell
-1,000
Closed -$156K – 8273
2025
Q3
$156K Sell
1,000
-1,200
-55% -$191K ﹤0.01% 4932
2025
Q2
$334K Sell
2,200
-10,700
-83% -$1.43M ﹤0.01% 3813
2025
Q1
$1.94M Sell
12,900
-3,900
-23% -$654K 0.01% 1833
2024
Q4
$3.1M Hold
16,800
– – 0.01% 1537
2024
Q3
$3.31M Buy
16,800
+200
+1% +$41.6K 0.01% 1334
2024
Q2
$3.43M Buy
+16,600
New +$3.76M 0.01% 1034
2023
Q3
– Sell
-7,500
Closed -$1.58M – 7731
2023
Q2
$1.58M Buy
7,500
+1,100
+17% +$219K 0.01% 1935
2023
Q1
$1.29M Sell
6,400
-40,100
-86% -$9.09M ﹤0.01% 1916
2022
Q4
$10.1M Buy
+46,500
New +$10.2M 0.02% 731
2022
Q2
– Sell
-37,200
Closed -$10.6M – 7918
2022
Q1
$10.6M Buy
37,200
+37,000
+18,500% +$11.4M 0.01% 959
2021
Q4
$75K Buy
+200
New +$77.7K ﹤0.01% 5980
2021
Q3
– Sell
-400
Closed -$148K – 8241
2021
Q2
$148K Sell
400
-1,400
-78% -$467K ﹤0.01% 5555
2021
Q1
$522K Buy
1,800
+800
+80% +$222K ﹤0.01% 3981
2020
Q4
$250K Buy
+1,000
New +$238K ﹤0.01% 3893
2019
Q2
– Sell
-3,000
Closed -$436K – 5018
2019
Q1
$436K Hold
3,000
– – ﹤0.01% 2055
2018
Q4
$340K Buy
+3,000
New +$376K ﹤0.01% 2267
2016
Q1
– Sell
-6,800
Closed -$547K – 4609
2015
Q4
$547K Hold
6,800
– – 0.01% 1753
2015
Q3
$432K Buy
6,800
+5,300
+353% +$381K 0.01% 1893
2015
Q2
$106K Buy
+1,500
New +$111K ﹤0.01% 3036
2014
Q3
– Sell
-3,000
Closed -$161K – 5172
2014
Q2
$161K Sell
3,000
-4,500
-60% -$247K ﹤0.01% 2590
2014
Q1
$453K Buy
7,500
+2,900
+63% +$169K 0.01% 1714
2013
Q4
$244K Buy
4,600
+1,200
+35% +$60.3K ﹤0.01% 2255
2013
Q3
$157K Buy
3,400
+300
+10% +$13.8K ﹤0.01% 2602
2013
Q2
$127K Buy
+3,100
New +$133K ﹤0.01% 2588

Other funds holding CRL

Group One Trading's CRL Position: Q3 2026 in Review

Group One Trading increased its Charles River Laboratories (CRL) stake by 358% in Q3 2026, buying an estimated $1.48M and bringing the position to 7,198 shares worth $2.12M. The position accounts for ﹤0.01% of the portfolio, ranked #2092.

Group One Trading first reported a position in CRL in Q2 2013 and has held it in 25 quarters since. 644 funds tracked by Wall St. Rank hold CRL as of Q3 2026.

  • Group One Trading held 7,198 shares of Charles River Laboratories worth $2.12M as of Q3 2026.
  • Group One Trading bought 5,625 Charles River Laboratories shares in Q3 2026, an estimated $1.48M.
  • Charles River Laboratories made up ﹤0.01% of Group One Trading's portfolio in Q3 2026, its #2092 holding.
  • Group One Trading first reported a position in Charles River Laboratories in Q2 2013 and has held it in 25 quarters since.
  • 644 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2026.

Based on Group One Trading's 13F filing for Q3 2026, filed 10 Nov 2026.